217-IL) inhibits IL-1 beta secretion in LPS-activated human peripheral blood mononuclear cells (PBMC) in a dose-dependent manner (orange line), as measured by the Human IL-1 beta /IL-1F2 Quantikine ELISA Kit (Catalog #
DLB50). IL-1 beta secretion inhibited by Recombinant Human IL-10 (0.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-10 R beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF874). The ND
50 is typically 2-6 µg/mL in the presence of LPS (0.25 ng/mL)." class="big_lightbox">

217-IL) inhibits IL-1 beta secretion in LPS-activated human peripheral blood mononuclear cells (PBMC) in a dose-dependent manner (orange line), as measured by the Human IL-1 beta /IL-1F2 Quantikine ELISA Kit (Catalog #
DLB50). IL-1 beta secretion inhibited by Recombinant Human IL-10 (0.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-10 R beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF874). The ND
50 is typically 2-6 µg/mL in the presence of LPS (0.25 ng/mL)." alt="Recombinant Human IL-10 (Catalog #
217-IL) inhibits IL-1 beta secretion in LPS-activated human peripheral blood mononuclear cells (PBMC) in a dose-dependent manner (orange line), as measured by the Human IL-1 beta /IL-1F2 Quantikine ELISA Kit (Catalog #
DLB50). IL-1 beta secretion inhibited by Recombinant Human IL-10 (0.25 ng/mL) is neutralized (green line) by increasing concentrations of Goat Anti-Human IL-10 R beta Antigen Affinity-purified Polyclonal Antibody (Catalog # AF874). The ND
50 is typically 2-6 µg/mL in the presence of LPS (0.25 ng/mL)." class="big_thumb" />